Your browser doesn't support javascript.
loading
Incidence rate and prevalence of pediatric-onset multiple sclerosis in Sweden: A population-based register study.
Sandesjö, Fredrik; Tremlett, Helen; Fink, Katharina; Marrie, Ruth Ann; Zhu, Feng; Wickström, Ronny; McKay, Kyla A.
Afiliación
  • Sandesjö F; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Tremlett H; Division of Neurology, Department of Medicine, The Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Fink K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Marrie RA; Department of Internal Medicine, Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Zhu F; Division of Neurology, Department of Medicine, The Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Wickström R; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • McKay KA; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Eur J Neurol ; 31(5): e16253, 2024 May.
Article en En | MEDLINE | ID: mdl-38369806
ABSTRACT
BACKGROUND AND

PURPOSE:

Pediatric-onset multiple sclerosis (PoMS) is associated with high health care use. To plan resource allocation for this patient group, knowledge of the incidence rate and prevalence is important. However, such studies are scarce, few are population-based, and the methodology varies widely. We aimed to address this knowledge gap by performing a nationwide study of the incidence rate and prevalence of PoMS in Sweden, an area of high multiple sclerosis (MS) incidence and prevalence.

METHODS:

MS cases were identified by linking two nationwide registers, the National Patient Register and the Swedish MS Registry. MS cases having their first central nervous system demyelinating event or MS clinical onset before age 18 years were classified as pediatric onset. Incidence rate and prevalence were estimated annually over the study period (2006-2016) for the total population and stratified by sex and age group (<12, 12-15, and 16-17 years). Temporal trends and ratios between sexes and age groups were estimated.

RESULTS:

We identified 238 incident cases from 2006 to 2016, corresponding to an overall crude incidence rate of 1.12 per 100,000 person-years and an overall crude prevalence of 2.82 per 100,000 population. There was a higher incidence rate among females and the highest age category. The overall incidence rate and prevalence estimates remained stable during the study period.

CONCLUSIONS:

Sweden exhibits a consistently high incidence rate and prevalence of PoMS that has remained stable over time. This knowledge serves as a tool to aid in planning resource allocation and health services for this patient population.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Límite: Adolescent / Child / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Límite: Adolescent / Child / Female / Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Suecia